Structurally rigid dopamine d3 receptor selective ligands and process for making them
AssigneeUniversity of North Texas Health Science Center at Fort Worth
InventorsAmy Newman, Peter Grundt, Robert R. Luedtke
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of North Texas Health Science Center at Fort Worth
InventorsAmy Newman, Peter Grundt, Robert R. Luedtke
Estimating the term…
A family of structurally rigid dopamine D3 receptor selective ligands is described. The family of structurally rigid dopamine D3 receptor selective ligands has the formula wherein A is cis or trans —CH═CH—, —C═C—, or cyclohexyl. B is cis or trans —CH═CH— or absent. R1 represents an optionally substituted phenyl group, wherein said substituents are selected from the group consisting of: hydrogen, halogen, amino, nitro, hydroxyl, alkoxy, alkyl, acyl and pyridyl, and said substitution may occur at any of the ortho, meta, or para positions, or R1 represents a heteroaromatic ring. A preferred heteroaromatic ring is indole, quinoxoline, pyridyl, pyrimidyl, or imidazole. R2 and R3 may be independently hydrogen or a halogen, or R2 alone may be C1, C2, or C3 alkoxy, and m is 1 or 2, and n is 0, 1, or 2.
A compound having the formula
Dependencies are inferred from the claim text.